Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Kelun Wins World’s First TROP2 ADC Approval In Lung Cancer
13 Mar 2025
•
By
Dexter Jie Yan
Merck/Kelun and AstraZeneca/Daiichi Sankyo are locked in a race to win lung cancer labels for their TROP2 ADCs.
(Shutterstock)
More from Clinical Trials
More from Focus On Asia